Metuchen Pharms Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for METUCHEN PHARMS, and what generic alternatives to METUCHEN PHARMS drugs are available?
METUCHEN PHARMS has one approved drug.
There are two US patents protecting METUCHEN PHARMS drugs.
There are fifty-three patent family members on METUCHEN PHARMS drugs in twenty-six countries and eleven supplementary protection certificates in eleven countries.
Drugs and US Patents for Metuchen Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Metuchen Pharms | STENDRA | avanafil | TABLET;ORAL | 202276-002 | Apr 27, 2012 | RX | Yes | No | 6,656,935 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Metuchen Pharms | STENDRA | avanafil | TABLET;ORAL | 202276-003 | Apr 27, 2012 | RX | Yes | Yes | 7,501,409 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Metuchen Pharms | STENDRA | avanafil | TABLET;ORAL | 202276-003 | Apr 27, 2012 | RX | Yes | Yes | 6,656,935 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Metuchen Pharms | STENDRA | avanafil | TABLET;ORAL | 202276-001 | Apr 27, 2012 | RX | Yes | No | 6,656,935 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Metuchen Pharms | STENDRA | avanafil | TABLET;ORAL | 202276-002 | Apr 27, 2012 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Metuchen Pharms | STENDRA | avanafil | TABLET;ORAL | 202276-003 | Apr 27, 2012 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Metuchen Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Metuchen Pharms | STENDRA | avanafil | TABLET;ORAL | 202276-001 | Apr 27, 2012 | 7,501,409 | ⤷ Try a Trial |
Metuchen Pharms | STENDRA | avanafil | TABLET;ORAL | 202276-003 | Apr 27, 2012 | 7,501,409 | ⤷ Try a Trial |
Metuchen Pharms | STENDRA | avanafil | TABLET;ORAL | 202276-002 | Apr 27, 2012 | 7,501,409 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for METUCHEN PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 50 mg, 100 mg and 200 mg | ➤ Subscribe | 2016-04-27 |
International Patents for Metuchen Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2002012587 | ⤷ Try a Trial |
Brazil | PI0014526 | ⤷ Try a Trial |
Canada | 2383466 | ⤷ Try a Trial |
New Zealand | 522217 | ⤷ Try a Trial |
China | 1440393 | ⤷ Try a Trial |
Australia | 4114201 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Metuchen Pharms Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1219609 | SPC/GB13/071 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: AVANAFIL; REGISTERED: UK EU/1/13/841 20130621 |
1219609 | 13C0050 | France | ⤷ Try a Trial | PRODUCT NAME: AVANAFIL; REGISTRATION NO/DATE: EU/1/13/841 20130621 |
1219609 | 476 | Finland | ⤷ Try a Trial | |
1219609 | 122013000096 | Germany | ⤷ Try a Trial | PRODUCT NAME: AVANAFIL UND SEINE PHARMAZEUTISCH ANNEHMBAREN SALZE; REGISTRATION NO/DATE: EU/1/13/841 20130621 |
1219609 | 92249 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: AVANAFIL |
1219609 | 2013/041 | Ireland | ⤷ Try a Trial | PRODUCT NAME: AVANAFIL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/13/841 20130613 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.